国产成人嫩模一区二区|超级黄色网页|兔子先生tz|麻豆文化传媒网站官网污|在线播放欧美日韩精品|爱豆影视传媒免费下载|蜜桃影像传媒av剧情|麻豆文化传媒APP最新iOS|陈可心倩女幽魂爱豆传媒|91国视频产,国产传媒播放,想看三级片,网红吃瓜黑料爆料网反差

Innovations in endovascular devices and endovascular procedures, data mining of peripheral vascular diseases with artificial intelligence technology.

Biological mechanisms of aging, inflammation, and remodeling of vascular walls. Mainly focused on vascular endothelial cells, macrophage cells, and platelets.

Multi-omics study of vascular diseases, including proteome, single-cell transcriptome, m6A modification, glycosylation, and metabolome.

More than 200 papers (including 123 SCI papers) have been published as the first or corresponding author, JCR Q1 > 50 papers, The full list of publications is available on ResearchGate (https://www.researchgate.net/profile/Xinwu-Lu) 41 patents, including 5 in the process of transformation.

Chief Surgeon, Professor of Department of Vascular Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine

Chairman, Shanghai Jiao Tong University Vascular Disease Forum (SJVF),

Director, Shanghai Jiao Tong University Vascular Disease Center,

First vice President, Vascular surgery committee of Shanghai medical association,

First vice President, Vascular surgery committee of Shanghai physicians association,

President, vascular malformations committee of Chinese medical doctor association,

President, vascular malformations committee of Traditional Chinese medicine association,

President, peripheral vascular committee of Chinese medicine Intervention association,

Member, the American Society for Vascular Surgery (SVS),

Member, the European Society for Vascular Surgery (ESVS),

Editorial board member and reviewer, 14 SCI journals (AVS, Biomaterials, JVS, EJVES,  etc.) and 10 Chinese journals (Chinese Medical Journal, Chinese Journal of Surgery, Chinese Journal of General Surgery, Chinese Journal of Experimental Surgery, etc.),